miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells
Related Experiment Video
Updated: Feb 5, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Yong Li1, Ping Gong2, Ji-Xue Hou3
1Department of Radiology, Suining Central Hospital, Suining, Sichuan Province 629000, China.
Abstract:
Although aberrant expression of miR-34a, an essential tumor suppressor miRNA, has been frequently observed in colon cancer (CCa), whether miR-34a can regulate CCa progression by modulating other facets of this malignancy (such as multidrug resistance, MDR) remains unknown. Here, we report for the first time that miR-34a expression was significantly downregulated in clinical CCa samples from oxaliplatin-resistant patients and in experimentally established multidrug-resistant CCa cells. By using histoculture drug response assay, we further confirmed that clinical CCa samples with lower miR-34a expression appeared to be more resistant to chemotherapy. Functionally, ectopic expression of exogenous miR-34a resensitized multidrug-resistant HCT-8/OR cells to oxaliplatin treatment, whereas miR-34a inhibition augmented the oxaliplatin resistance in chemosensitive HCT-8 cells. Mechanistically, miR-34a positively regulated the mRNA stability of the ornithine decarboxylase antizyme 2 (OAZ2) by directly targeting its three prime untranslated region (3'UTR). Consequently, suppression of the expression of miR-34a/OAZ2 signaling by chemotherapeutic agents significantly enhanced the activation of MDR-associated ATP-binding cassette (ABC) transporters and antiapoptosis pathways, thus leading to MDR development in CCa cells. Collectively, our combined analysis reveals a critical role of miR-34a/OAZ2 cascade in conferring a proper cellular response to CCa chemotherapy.
Insights
MicroRNA-34a (miR-34a) downregulation promotes colon cancer multidrug resistance (MDR). Restoring miR-34a resensitizes cells to chemotherapy by targeting OAZ2, impacting MDR pathways.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant microRNA-34a (miR-34a) expression is linked to colon cancer (CCa).
- The role of miR-34a in colon cancer multidrug resistance (MDR) is not fully understood.
Purpose of the Study:
- To investigate the role of miR-34a in colon cancer progression and multidrug resistance.
- To elucidate the molecular mechanism by which miR-34a influences chemotherapy response in CCa.
Main Methods:
- Analysis of miR-34a expression in clinical CCa samples and cell lines.
- Histoculture drug response assay to assess chemotherapy sensitivity.
- Functional studies involving ectopic miR-34a expression and inhibition.
- Luciferase reporter assays to confirm direct targeting of OAZ2 by miR-34a.
Main Results:
- miR-34a was significantly downregulated in oxaliplatin-resistant CCa tissues and cells.
- Lower miR-34a expression correlated with increased resistance to chemotherapy.
- miR-34a re-sensitized resistant cells to oxaliplatin and its inhibition enhanced resistance in sensitive cells.
- miR-34a directly targets ornithine decarboxylase antizyme 2 (OAZ2) mRNA, stabilizing its expression.
Conclusions:
- The miR-34a/OAZ2 cascade plays a critical role in regulating colon cancer cell response to chemotherapy.
- Downregulation of miR-34a contributes to MDR development in CCa by affecting OAZ2 stability and downstream pathways.
- Targeting the miR-34a/OAZ2 pathway may offer a therapeutic strategy to overcome MDR in colon cancer.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
09:20An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
Related Concept Videos
Positive Regulator Molecules
Positive Regulator Molecules
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Treatment Resistant Cancers
What is Cell Signaling?
mTOR Signaling and Cancer Progression
The mTOR pathway or the...